ZIMLAB

ZIM LABORATORIES

Small Cap BSE: 541400 NSE: ZIMLAB
₹326.4
6.35 (1.98%)
As on 07 December, 2022 | 08:33

Zim Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in ZIM LABORATORIES

Start SIP

Zim Laboratories Share Price

Zim Laboratories Share Returns

  • Over 1 Month 22.25%
  • Over 3 Month 25.61%
  • Over 6 Month 44.46%
  • Over 1 Year 198.76%

Zim Laboratories Key Statistics

P/E Ratio 24.4
PEG Ratio 0.1
Market Cap Cr 530
Price to Book Ratio 3
EPS 8
Dividend 0
Relative Strength Index 56.09
Money Flow Index 56.22
MACD Signal 16.01
Average True Range 18.53

Zim Laboratories Investment Rating

  • Master Rating:
  • Zim Laboratories has an operating revenue of Rs. 383.93 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 6% is okay, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 11%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 14% and 45% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 11% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 70 which is a FAIR score but needs to improve its earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 110 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Zim Laboratories Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 999310486766473
Operating Expenses Qtr Cr 87819075675965
Operating Profit Qtr Cr 12111411959
Depreciation Qtr Cr 4444434
Interest Qtr Cr 1112333
Tax Qtr Cr 3242101
Net Profit Qtr Cr 6664201

Zim Laboratories Technicals

EMA & SMA

Current Price
326.4
6.35 (1.98%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 319.75
  • 50 Day
  • 293.36
  • 100 Day
  • 265.45
  • 200 Day
  • 230.84
  • 20 Day
  • 332.37
  • 50 Day
  • 281.88
  • 100 Day
  • 257.55
  • 200 Day
  • 221.57

Zim Laboratories Resistance and Support

PIVOT
₹320.4
Resistance
First Resistance 330.8
Second Resistance 341.55
Third Resistance 351.95
RSI 56.09
MFI 56.22
MACD Single Line 16.02
MACD 11.08
Support
First Resistance 309.65
Second Resistance 299.25
Third Resistance 288.5

Zim Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 10,271 730,063 71.08
Week 9,781 658,386 67.31
1 Month 11,155 856,808 76.81
6 Month 4,444 342,235 77.01

Zim Laboratories Result Highlights

Zim Laboratories Synopsis

NSE-Medical-Generic Drugs

Zim Laboratories is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 329.49 Cr. and Equity Capital is Rs. 16.24 Cr. for the Year ended 31/03/2022. Zim Laboratories Ltd. is a Public Limited Listed company incorporated on 14/02/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1984PLC032172 and registration number is 032172.
Market Cap 526
Sales 382
Shares in Float 1.09
No of funds
Yield
Book Value 3.09
U/D Vol ratio 0.9
LTDebt / Equity 11
Alpha 0.46
Beta 0.63

Zim Laboratories

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 33.26%33.26%33.26%
Individual Investors 50.96%51.15%50.77%
Others 15.78%15.59%15.97%

Zim Laboratories Management

Name Designation
Dr. Anwar Daud Chairman & Managing Director
Mr. Zulfiquar M Kamal Director - Finance
Mr. Prakash Sapkal Director - Operations
Mr. Niraj Dhadiwal Director - Business Development
Mr. Padmakar Joshi Independent Director
Dr. Kamlesh Shende Independent Director
Dr. Kakasaheb Mahadik Independent Director
Mrs. Kavita Loya Independent Director

Zim Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Zim Laboratories Corporate Action

Date Purpose Remarks
2022-11-12 Quarterly Results & Bonus issue
2022-07-26 Quarterly Results
2022-05-21 Audited & Quarterly Results
2022-01-31 Quarterly Results
2021-10-30 Quarterly Results

Zim Laboratories FAQs

What is Share Price of Zim Laboratories ?

Zim Laboratories share price is ₹326 As on 07 December, 2022 | 08:19

What is the Market Cap of Zim Laboratories ?

The Market Cap of Zim Laboratories is ₹530.1 Cr As on 07 December, 2022 | 08:19

What is the P/E ratio of Zim Laboratories ?

The P/E ratio of Zim Laboratories is 24.4 As on 07 December, 2022 | 08:19

What is the PB ratio of Zim Laboratories ?

The PB ratio of Zim Laboratories is 3 As on 07 December, 2022 | 08:19

Q2FY23